ATE349533T1 - Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen - Google Patents

Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen

Info

Publication number
ATE349533T1
ATE349533T1 AT01952368T AT01952368T ATE349533T1 AT E349533 T1 ATE349533 T1 AT E349533T1 AT 01952368 T AT01952368 T AT 01952368T AT 01952368 T AT01952368 T AT 01952368T AT E349533 T1 ATE349533 T1 AT E349533T1
Authority
AT
Austria
Prior art keywords
polypeptides
diagnosis
treatment
composition
herpes simplex
Prior art date
Application number
AT01952368T
Other languages
English (en)
Inventor
Nancy A Hosken
Craig H Day
Davin C Dillon
Patrick Mcgowan
Paul R Sleath
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of ATE349533T1 publication Critical patent/ATE349533T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/464838—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G01N2333/035—Herpes simplex virus I or II

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01952368T 2000-06-29 2001-06-28 Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen ATE349533T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21545800P 2000-06-29 2000-06-29
US27743801P 2001-03-20 2001-03-20

Publications (1)

Publication Number Publication Date
ATE349533T1 true ATE349533T1 (de) 2007-01-15

Family

ID=26910047

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01952368T ATE349533T1 (de) 2000-06-29 2001-06-28 Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen

Country Status (9)

Country Link
US (1) US6537555B2 (de)
EP (1) EP1297147B8 (de)
JP (1) JP2004501663A (de)
AT (1) ATE349533T1 (de)
AU (2) AU2001273128C1 (de)
CA (1) CA2411692A1 (de)
DE (1) DE60125537D1 (de)
NZ (1) NZ522734A (de)
WO (1) WO2002002131A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002317604A1 (en) * 2001-07-31 2003-02-17 Corixa Corporation Immunologically significant herpes simplex virus antigens and methods for using same
DK2011510T3 (da) 2002-07-18 2011-03-28 Univ Washington Farmaceutiske sammensætninger indeholdende immunologisk aktive Herpes simplex-virus(HSV) proteinfragmenter
WO2005028496A2 (en) * 2003-09-12 2005-03-31 Antigenics, Inc. Vaccine for treatment and prevention of herpes simplex virus infection
US20070184472A1 (en) * 2005-06-08 2007-08-09 Toagosei Co., Ltd Method of purifying environmental dna and method of efficiently screening for protein-encoding gene from environmental dna
US7763460B2 (en) * 2005-06-24 2010-07-27 Focus Diagnostics, Inc. Methods and compositions for detecting herpes simplex virus type 2
US8460674B2 (en) * 2009-02-07 2013-06-11 University Of Washington HSV-1 epitopes and methods for using same
EP2413950A4 (de) 2009-04-03 2013-05-01 Univ Washington Antigenes hsv-2-peptid und verwendungsverfahren dafür
HUE028642T2 (en) * 2009-04-20 2016-12-28 Galen Bio Inc Preparations for incorporating biomolecules into cells
CN102458463B (zh) 2009-05-22 2017-01-18 健诺西生物科学公司 针对ⅱ型单纯疱疹病毒的疫苗：诱发免疫应答的组合物和方法
WO2011132078A2 (en) 2010-04-23 2011-10-27 Genomic Vision Diagnosis of viral infections by detection of genomic and infectious viral dna by molecular combing
WO2012061637A2 (en) * 2010-11-03 2012-05-10 University Of Washington Hsv-1 epitopes and methods for using same
US9782474B2 (en) 2010-11-24 2017-10-10 Genocea Biosciences, Inc. Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
AU2012212264B2 (en) * 2011-01-31 2016-01-28 The Trustees Of The University Of Pennsylvania Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof
US9624273B2 (en) 2011-11-23 2017-04-18 Genocea Biosciences, Inc. Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
WO2016071925A2 (en) * 2014-11-05 2016-05-12 Indian Council Of Medical Research (Icmr) TITLE: INTEGRATION OF β-ACTIN GENE FOR SAMPLE QUALITY CHECK IN HSV-1 AND HSV-2 DIAGNOSTIC KIT
US10350288B2 (en) 2016-09-28 2019-07-16 Genocea Biosciences, Inc. Methods and compositions for treating herpes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW232710B (de) 1991-09-13 1994-10-21 American Cyanamid Co
GB9401333D0 (en) * 1994-01-25 1994-03-23 Medical Res Council Herpes virus pre-(viral dna replication) particles (preps)
JP2001508649A (ja) * 1996-11-04 2001-07-03 スミスクライン・ビーチャム・コーポレイション ２型単純ヘルペスウイルス由来の新規コーディング配列
CA2291010A1 (en) 1997-06-02 1998-12-10 Chiron Corporation Herpes simplex virus vp22 vaccines and methods of use

Also Published As

Publication number Publication date
US6537555B2 (en) 2003-03-25
NZ522734A (en) 2005-05-27
WO2002002131A3 (en) 2003-01-03
EP1297147B1 (de) 2006-12-27
CA2411692A1 (en) 2002-01-10
US20020090610A1 (en) 2002-07-11
AU7312801A (en) 2002-01-14
DE60125537D1 (de) 2007-02-08
AU2001273128B2 (en) 2006-03-16
JP2004501663A (ja) 2004-01-22
EP1297147A2 (de) 2003-04-02
AU2001273128C1 (en) 2006-09-21
WO2002002131A2 (en) 2002-01-10
EP1297147B8 (de) 2007-02-21

Similar Documents

Publication Publication Date Title
ATE373092T1 (de) Zusammensetzungen und verfahren zur behandlung von chlamydia-infektionen
WO2003086308A3 (en) Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
NZ518917A (en) Compounds and methods for treatment and diagnosis of chlamydial infection
DE69942426D1 (de) Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
ATE389020T1 (de) Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
WO1998042740A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
WO2003041560A3 (en) Compounds and methods for treatment and diagnosis of chlamydial infection
WO2000000615A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
WO2001085949A3 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
EP0834567A3 (de) Zusammensetzungen und Verfahren zur Diagnose und Behandlung von Babesia microti Infektion
WO2003020108A3 (en) Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
WO2002053016A3 (en) Compounds and methods for the diagnosis and treatment of babesia infection

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties